Digital repository of Slovenian research organisations

Show document
A+ | A- | Help | SLO | ENG

Title:Comparison of colorimetric MTT and clonogenic assays for irradiation and cisplatin treatment on murine fibrosarcoma SA-1 cells
Authors:ID Čemažar, Maja (Author)
ID Marolt, Darja (Author)
ID Lavrič, Mira (Author)
ID Serša, Gregor (Author)
Files:.pdf PDF - Presentation file, download (419,17 KB)
MD5: ABDA2225A3ED2EAE7BA696B60DD6E21F
 
Language:English
Typology:1.01 - Original Scientific Article
Organization:Logo OI - Institute of Oncology
Abstract:Background. The aim of our study was to determine the relationship between cell survival of SA-1 tumor cells measured by clonogenic assay and MTT assay after irradiation and cisplatin treatment. Materials and methods. Survival of SA-1 cells was measured after irradiation (2-8 Gy) and cisplatin treatment (0.05-0.5 u g/ml) by clonogenic assay performed 7 days after treatment, and byMTT assay performed on day 3, 4, 5, and 7 after the treatment. Results. The results showed good correlation between MTT assay and clonogenic assay for irradiation doses below 4 Gy. For higher doses good correlation between MTT and clonogenic assay was determined only when MTT assay was performed on day 5and 7 after the treatment. In the case of cisplatin treatment, similar pattern was observed, good correlation between IC50 values for MTT and clonogenic assay was found when MTT assay was performed on day 5 and 7 after the treatment. Conclusion. Results of our study confirmed the results of previous studies addressing this topic and further support the use of MTT testas an alternative test for clonogenic test as a predictive assay of tumourresponse to the radio or chemotherapy.
Publication status:Published
Publication version:Version of Record
Publication date:01.12.1999
Publisher:Slovenian Medical Association - Slovenian Association of Radiology, Nuclear Medicine Society, Slovenian Society far Radiotherapy and Oncology, and Slovenian Cancer Society
Year of publishing:1999
Number of pages:str. 303-308
Numbering:Letn. 33, št. 4
Source:Ljubljana
PID:20.500.12556/DiRROS-17927 New window
UDC:616-006
ISSN on article:1318-2099
COBISS.SI-ID:11071449 New window
Copyright:by Authors
Note:BSDOCID49530;
Publication date in DiRROS:22.01.2024
Views:560
Downloads:117
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Record is a part of a journal

Title:Radiology and oncology
Shortened title:Radiol. oncol.
Publisher:Slovenian Medical Society - Section of Radiology, Croatian Medical Association - Croatian Society of Radiology
ISSN:1318-2099
COBISS.SI-ID:32649472 New window

Secondary language

Language:Slovenian
Title:Primerjava kolorimetričnega testa MTT in testa klonogenosti na mišjih fibrosarkomskih SA-1 celicah po obsevanju in zdravljenju s cisplatinom
Abstract:Izhodišče. Namen naše raziskave je bil določiti povezavo med testom MTT in testom klonogenosti z merjenjem preživetja SA-1 tumorskih celic po obsevanju in po terapiji s cisplatinom. Materiali in metode. Preživetje SA-1 celic smo določali po obsevanju celic (2-8 Gy) ali po terapiji s cisplatinom (0.05 - 0.5ug/ml) s testom klonogenosti, ki smo ga izvedli 7 dan po terapiji, ter testom MTT, ki smo ga izvedli 3., 4., 5., in 7. po terapiji. Rezultati. Ugotovili smo, da testa dobro korelirata, ko smo celice obsevali z dozami pod 4 Gy. Pri višjih dozah obsevanja sta test MTT in test klonogenosti dobro korelirala samo v primeru, ko smo merili preživetje celic z testom MTT 5. in 7. dan po obsevanju. Po terapiji s cisplatinom smo dobili podobne rezultate; korelacija med testom MTT in testom klonogenosti je bila dobra v primeru, ko smo izvedli test MTT 5. in 7. dan po terapiji. Zaključki. Rezultati naše raziskave so potrdili ugotovitve predhodnih študij, ter podpirajo uporabo testa MTT kot alternativo testu klonogenosti pri napovedovanju izida zdravljenja tumorjev z radio- in kemoterapijo.


Back